Non-Dopaminergic Therapies

Serotonin, β-amyloid, and cognition in Parkinson disease

(2018) Vikas Kotagal et al.   ANNALS OF NEUROLOGY

Convergent Mechanisms Underlying Rapid Antidepressant Action

(2018) Panos Zanos et al.   CNS DRUGS

Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System

(2018) Jose Luis Cortes-Altamirano et al.   Current Neuropharmacology

Network imaging biomarkers: insights and clinical applications in Parkinson's disease

(2018) Katharina A Schindlbeck et al.   LANCET NEUROLOGY

Zinc ions regulate opening of tight junction favouring efflux of macromolecules via the GSK3β/snail-mediated pathway

(2018) Ruyue Xiao et al.   Metallomics

Diabetes mellitus and Parkinson disease

(2018) Gennaro Pagano et al.   NEUROLOGY

Association between diabetes and subsequent Parkinson disease

(2018) Eduardo De Pablo-Fernandez et al.   NEUROLOGY

Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications

(2018) Roberta Balestrino et al.   NEUROSCIENTIST

An updated diagnostic approach to subtype definition of vascular parkinsonism – Recommendations from an expert working group

(2018) Ivan Rektor et al.   PARKINSONISM & RELATED DISORDERS

Post hoc analysis of the Exenatide-PD trial - factors that predict response

(2018) Dilan Athauda et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

GBA-Associated Parkinson’s Disease: Progression in a Deep Brain Stimulation Cohort

(2017) Vanessa Lythe et al.   Journal of Parkinsons Disease

Pharmacological Treatment and Prevention of Cerebral Small Vessel Disease: A Review of Potential Interventions

(2015) Philip M. Bath et al.   International Journal of Stroke

Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects

(2015) Nicolaas I. Bohnen et al.   JAMA Neurology

Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: Anin vivopositron emission tomography study

(2014) Nicolaas I. Bohnen et al.   MOVEMENT DISORDERS

The Next Step

(2014) Simon J. G. Lewis et al.   NEUROSCIENTIST

Prevalence, Determinants, and Effect on Quality of Life of Freezing of Gait in Parkinson Disease

(2014) Santiago Perez-Lloret et al.   JAMA Neurology

St. John's Wort Reduces Beta-Amyloid Accumulation in a Double Transgenic Alzheimer's Disease Mouse Model-Role of P-Glycoprotein

(2013) Anja Brenn et al.   BRAIN PATHOLOGY

Sleep Drives Metabolite Clearance from the Adult Brain

(2013) L. Xie et al.   SCIENCE

A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid  

(2012) J. J. Iliff et al.   Science Translational Medicine

Serotonin signaling is associated with lower amyloid-  levels and plaques in transgenic mice and humans

(2011) J. R. Cirrito et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Motor complications in Parkinson's disease: Ten year follow-up study

(2010) Iria Cabo López et al.   MOVEMENT DISORDERS

Modes and Models of Forebrain Cholinergic Neuromodulation of Cognition

(2010) Michael E Hasselmo et al.   NEUROPSYCHOPHARMACOLOGY